Paul Asbury Monach, M.D., Ph.D.
This page shows the publications co-authored by Paul Monach and Westyn Branch-Elliman.
Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial. PLoS One. 2022; 17(2):e0263591.
Reconsidering 'minimal risk' to expand the repertoire of trials with waiver of informed consent for research. BMJ Open. 2021 09 14; 11(9):e048534.
Aspirin Dosing in Cardiovascular Disease. N Engl J Med. 2021 Aug 19; 385(8):764.
Not What Anyone Signed up for: Unnecessary and Insurmountable Barriers Encountered in Conducting Clinical Trials in COVID-19. Narrat Inq Bioeth. 2021; 11(1):8-15.
Bringing New Meaning to the Term "Adaptive Trial": Challenges of Conducting Clinical Research During the Coronavirus Disease 2019 Pandemic and Implications for Implementation Science. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa490.
Pragmatic, adaptive clinical trials: Is 2020 the dawning of a new age? Contemp Clin Trials Commun. 2020 Sep; 19:100614.
Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study. Vaccine. 2022 02 16; 40(8):1082-1089.
The COVID-19 Hospitalization Metric in the Pre- and Post-vaccination Eras as a Measure of Pandemic Severity: A Retrospective, Nationwide Cohort Study. Infect Control Hosp Epidemiol. 2022 Jan 11; 1-24.
Implementation of documented and written informed consent for clinical trials of communicable diseases: Lessons learned, barriers, solutions, future directions identified during the conduct of a COVID-19 clinical trial. Contemp Clin Trials Commun. 2021 Sep; 23:100804.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.